Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Vivani Medical, Inc.
VANI · SEC Filings
website
42
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of mini...
Price
1.125
Market Cap
101.93 M
Float
43.65 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about VANI
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Vivani Medical, Inc.
VANI · SEC Filings
43.65 M
Float
1.125
Price
101.93 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025
News
TYPE
HEADLINE
FILED AT
8-K
Vivani Medical Provides Update on Pending Merger of Cortigent with ClearOne
Oct 30, 2026
8-K
Vivani Medical Files Form 8-K to Disclose Investor Slide Presentation
Oct 29, 2026
8-K
Vivani Medical Anticipates October 2026 Closing for Cortigent Merger with ClearOne
Sep 16, 2026
8-K
Vivani Medical, Inc. Releases Updated Corporate Slide Presentation
Aug 17, 2026
8-K
Vivani Medical Reports Q2 2026 Financial Results and Business Progress
Aug 13, 2026
8-K
Vivani Medical Completes Enrollment and Dosing for SLIM-1 Phase 1 Trial of NPM-139 Semaglutide Implant
Aug 6, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
SHARE RESALE REGISTRATION | Shares: 3,947,368
Sep 25, 2026
424B5
REGISTERED OFFERING
Jan 27, 2026
424B5
REGISTERED OFFERING
Oct 27, 2025
424B5
3,947,368 Shares of Common Stock
Mar 5, 2024
425
20,025,356
Jul 29, 2022
425
Registration
Jul 18, 2022
Registrations
TYPE
HEADLINE
FILED AT
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
May 6, 2024
CORRESP
Form CORRESP - Correspondence
May 2, 2024
LETTER
Form UPLOAD - SEC-generated letter
Apr 29, 2024
EFFECT
Form EFFECT - Notice of Effectiveness
Jun 27, 2022
CORRESP
Form CORRESP - Correspondence
Jun 22, 2022
LETTER
Form UPLOAD - SEC-generated letter
May 23, 2022
